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Abstract: Among metal oxides, zinc oxide (ZnO) is one of the most attractive materials thanks to
its biocompatible and biodegradable properties along with the existence of various morphologies
featuring piezoelectric, semiconducting and photocatalytic activities. All of these structures were
successfully prepared and tested for numerous applications, including optoelectronics, sensors and
biomedical ones. In the last case, biocompatible ZnO nanomaterials positively influenced cells growth
and tissue regeneration as well, promoting wound healing and new bone formation. Despite showing
high surface areas, ZnO morphologies generally lack an intrinsic mesoporous structure, strongly
limiting the investigation of the corresponding drug loading and release properties. Within this
scope, this study focuses on the adsorption and release properties of high surface area, mesoporous
ZnO structures using gentamicin sulfate (GS), a well known antibiotic against bacterial infections
especially in orthopedics. The particular ZnO morphology was achieved starting from sputtered
porous zinc layers, finally converted into ZnO by thermal oxidation. By taking advantage of this
mesoporous framework, GS was successfully adsorbed within the ZnO matrix and the kinetic
release profile evaluated for up to seven days. The adsorption of GS was successfully demonstrated,
with a maximum amount of 263 mg effectively loaded per gram of active material. Then, fast kinetic
release was obtained in vitro by simple diffusion mechanism, thus opening further possibilities of
smart pore and surface engineering to improve the controlled delivery.
Keywords: zinc oxide; mesoporous structure; gentamicin sulfate; drug delivery
1. Introduction
Zinc oxide (ZnO) is a wide band-gap metal oxide semiconductor (3.37 eV) characterized
by the presence of piezoelectric [1] and pyroelectric [2] properties, biocompatibility [3,4] and
photocatalyitic activity [5,6]. This metal oxide may be prepared in a huge amount of morphologies
and shapes, like thin films [7,8], nanowires [9], nanorods [10], nanobelts [11], nanoparticles [12] and
flower-like structures [13]. All of the mentioned ZnO structures are easily obtained by following
wet and dry synthesis approaches, such as sol-gel and hydrothermal routes as well as vapor-phase
deposition methods.
Because of its multifunctional properties and the existence of various micro- and nanostructured
morphologies, ZnO has gained considerable attention and for different application fields.
The photocatalytic activity of ZnO was successfully demonstrated in numerous cases and for different
morphologies [5,6,14–17], finding application for water splitting [18,19] and degradation of dye
pollutants for waste-water treatments [20,21]. ZnO nanostructures with promising piezoelectric and
semiconducting properties were successfully obtained as well, resulting in novel smart materials
applicable for new generation energy harvesting systems [22–26] and sensing applications [8,23,27–31].
Concerning the biomedical field, ZnO was extensively investigated as active material for biosensing
applications [32–34]. To this purpose, many works highlighted the promising use of ZnO nanostructures
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for the detection of different biomoieties, like glucose [35–37], acid uric [38–40] and proteins [31,41].
More recently, the interest in studying ZnO nanomaterials for tissue engineering came up as well [4].
In particular, the ability of ZnO nanosheets, nanoflowers and nanorods to actively promote the growth
and proliferation of several cells line was reported [42–44], together with the successful demonstration
of ZnO proangiogenic [45] and osteogenic activities [43], particularly desirable for wound healing and
the formation of new bone tissue.
Despite showing high surface areas, many ZnO morphologies suffer from a major drawback,
the lack of an intrinsic mesoporous structure. Especially for drug delivery applications, this aspect
strongly limited their investigation as possible alternatives to other existing materials, like mesoporous
silica nanoparticles (MSNs) [46,47]. However, ZnO on its own is very sensitive towards pH variations.
This property was successfully exploited in the case of ZnO quantum dots [48], which were also
combined to doxorubicin-loaded MSNs and used as nanolids to cover silica nanopores [49]. In this
way, under specific pH variations ZnO nanolids allowed the opening of the pores and the controlled
delivery of doxorubicin. Exploiting ZnO decomposition in acidic environments, ZnO nanoparticles
were also combined into biodegradable polymers, resulting in core-shell structures with high loading of
doxorubicin amounts and pH-triggered release properties [50]. Mesoporous ZnO nanospheres showing
biocompatible properties were also successfully synthesized by a soluble-starch-insertion method.
The mesoporous structure effectively allowed for captopril drug molecules to be efficiently loaded and
released during in vitro experiments [51]. Alternatively, a porous hexagonal ZnO nanodisc structure
prepared by microwave synthesis was proposed as a nanocarrier for drug delivery applications.
After the chemical modification of the outer ZnO surface to improve the chemical stability and making
loading more efficient, the proposed system showed promising results for the targeted, pH-triggered
delivery of the anticancer drug against breast cancer cells [52]. Dandelion-like mesoporous ZnO
capsules mainly formed by ZnO nanorods or nanoparticles were proposed as well [53]. Also in this
case, interesting drug delivery properties were obtained and expressed in terms of doxorubicin loading
and release.
In this work, mesoporous ZnO structures were considered as active material and the related
drug loading and release properties evaluated. Gentamicin sulfate (GS), a bactericidal aminoglycoside
antibiotic, was selected as a drug molecule because of its wide use in the treatment of bacterial
infections like osteomyelitis. The existence of a mesoporous framework with specific physical and
chemical properties allowed the successful adsorption of GS within the ZnO matrix. The kinetic
release profile was then evaluated in vitro for up to seven days. The results showed that promising GS
adsorption could be obtained within 2 h of uptake experiment, with a maximum amount of 263 mg
effectively adsorbed per gram of active material. Then, by simple diffusion mechanism, fast GS release
was observed during in vitro experiments, as 90% GS delivery occurred within the first 2 h. These first
results point out the well-known need in mesoporous systems to further engineer the pore chemical
structure or entrance [47,54,55] in order to achieve a smart and even remote control on the drug
delivery kinetics.
2. Results
The surface morphology and cross-sectional structure of mesoporous ZnO structures grown on
silicon (Si) substrates are shown in Figure 1 and were investigated by means of Field Emission Scanning
Electron Microscopy (FESEM). The presence of a porous nanobranched network made of elongated,
nanocrystalline ZnO grains interconnected to each other was noticed, together with the formation
of cavities (see Figure 1b). The average thickness of the ZnO layer was around 9 µm. The degree of
porosity was previously estimated [56] and confirmed the existence of a mesoporous framework with
a discrete specific surface area (14 m2·g−1, pore volume 0.095 cm3·g−1), while an average pore diameter
of 27 nm could be estimated according to Wheeler equation [57]. Figure 1c,d show the X-ray Diffraction
(XRD) pattern and infrared (IR) spectrum of the mesoporous ZnO matrix. The sharp and intense XRD
peaks positioned at 31.80◦, 34.45◦ and 36.29◦ 2θ angles belong to (100), (002) and (101) crystal planes of
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hexagonal wurtzite ZnO, respectively (Joint Committee on Powder Diffraction Standards-International
Centre for Diffraction Data (JCPDS-ICDD) database, card no. 89–1397). Other minor contributions
at 47.61◦ and 56.67◦ were also detected and due to reflections coming from (102) and (110) wurtzite
crystal planes. On the other side, IR spectroscopy highlighted the presence of a hydroxyl-rich surface,
witnessed by the absorbance band at 3750 cm−1 due to stretching mode of free O−H, as well as by the
broad band lying in the range 3600–3100 cm−1 and due to OH of water of crystallization.
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solution simulating the inorganic composition of human plasma and derives from the formulation of 
Kokubo [58]. Figure 2 summarizes the effect of using GS/H2O and GS/SBF in the drug loading, 
remarking a degradation behavior of the ZnO matrix during GS loading in water solution. The time 
evolution of the corresponding pH value is shown in Figure 2a, while Figure 2b reports the release 
profile for Zn2+ ions against the soaking time, obtained by Inductively Coupled Plasma-Mass 
Spectrometry (ICP-MS). Actually, in the case of GS/H2O, the starting acidity of the loading solution 
(initial pH 4.4) led to a remarkable degradation of the mesoporous structure, as witnessed by the 
increasing amount of Zn2+ ions coming from the ZnO matrix and released in the uptake solution. The 
highest concentration value for Zn2+ (~110 ppm) was observed for the longest soaking time (24 h). 
The release of Zn2+ ions also induced a continuous increase of the pH value during time, as visible in 
Figure 2a. On the contrary, no remarkable degradation of the ZnO matrix occurred during drug 
loading by using GS/SBF buffered solution (initial pH 7.4), except for the beginning of the loading 
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Figure 1. Surface morphology of mesoporous zinc oxide (ZnO) structures obtained by Field-Emission
Scanning Electron Microscope (FESEM): (a) top and cross-section views—scale bar is 1 µm; (b) FESEM
image at higher magnification—scale bar is 100 nm; (c) X-ray diffraction pattern; (d) infrared spectrum.
The g ntamicin sulfate (GS) adsorpti r erties of mesop rous ZnO structures were
investigated by soaking the samples in t o separate uptake solutions and for different times (1, 2,
5 and 24 h): GS in water (GS/H2O) and GS in Simulated Body Fluid (GS/SBF). SBF is a buffered
solution simulating the inorganic composition of human plasma and derives from the formulation
of Kokubo [58]. Figure 2 summarizes the effect of using GS/H2O and GS/SBF in the drug loading,
remarking a degradation behavior of the ZnO matrix during GS loading in water solution. The time
evolution of the corresponding pH value is shown in Figure 2a, while Figure 2b reports the release
profile for Zn2+ ions against the soaking time, obtained by Inductively Coupled Plasma-Mass
Spectrometry (ICP-MS). Actually, in th case of GS/H2O, the starting a idity of the loading solution
(initial pH 4.4) led to a remarkable degrada ion of the mesoporou structure, s witnessed by the
increasing amou t of Zn2+ ions coming from the ZnO matrix and releas d in the uptake solution.
The highest concentration value for Zn2+ (~110 ppm) was observed for the longest soaking time (24 h).
The release of Zn2+ ions also induced a continuous increase of the pH value during time, as visible in
Figure 2a. On the contrary, no remarkable degradation of the ZnO matrix occurred during drug loading
by using GS/SBF buffered solution (initial pH 7.4), except for the beginning of the loading experiment;
within the first hour, release of Zn2+ ions were slightly comparable to the GS/H2O case, but then it
stabilized to a nearly constant level (~25–35 ppm) for the remaining part of the loading experiment.
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This time evolution profile of Zn2+ agreed with the corresponding evolution of pH; actually, the pH in
the SBF buffered solution did not change up to 24 h.
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Figure 2. Comparison of gentamicin sulfate (GS) loading experiments performed by using different
uptake solutions, i.e., GS/H2O vs. GS/SBF: (a) time evolution of pH; (b) ICP-MS release profile for
Zn2+ ions. Error bars for GS/SBF fall within the resolution limit of instrument.
By considering the strong ZnO degradation observed for the GS/H2O solution, the buffered
GS/SBF one was selected as the opti al choice for efficient GS loading, as it prevented the dissolution
of the mesoporous framework. Figure 3 shows the amount of GS effectively adsorbed within the
ZnO matrix against the loading time. By chang g the so king time f om 0 to 2 h, the a ount of GS
loaded within m so o ous ZnO incr ased accordingly, reaching a m ximum valu of 263 mg adsorbed
per gram of active material. If the loading time w further increased up to 5 h, no additional drug
adsorption was observed, as well s even up to 24 h (data not reported). Therefore, 2 h was selected as
the optimal soaking time to load the maximum amount of drug.
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Figure 3. Gent micin sulfate loading against time.
The effective GS adsorption was also verified by IR spectrosc py. Figure 4a shows the IR spectra
collected for ZnO samples after loading GS in SBF for up to 5 h. A br ad absorption band in the range
3500–3100 cm−1 was obse ved in all the c ses nd due to –OH vibrational modes. The presence of GS
was represented by he appearance of the sulfate band at 609 cm−1 and of C–O–C str tching mode at
1080 cm−1. However, this last one w s very close and partially overlapped with the intense PO43−
band lying in the range 1100–1000 cm−1 and due to the interaction of mesoporous ZnO with SBF
solution. Figure 4b shows the corresponding XRD patterns. No additional contributions were detected
while strong diffraction peaks belonging to hexagonal wurtzite ZnO were still present, independently
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of the soaking time. This confirmed that GS loading in SBF did not alter the structural properties of the
mesoporous ZnO framework, as the starting crystalline structure was completely preserved.
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Figure 4. Structural and compositional characterization of mesoporous zinc oxide structures after
loading gentamicin sulfate in SBF: (a) infrared spectra; (b) X-ray diffraction patterns.
After soaking ZnO sample in GS/SBF solution for 2 h, i.e., the optimal loading time, the effective
GS adsorption was qualitatively confirmed also by En rgy Dispersive X-r y Spectroscopy (EDS)
analysis. Apart from Zn (45.75 at %) and O (48 at %), the presence of S (0.03 at %), N (4.12 at %),
P (1.73 at %) and Ca (0.37 at %) elements was noticed, as shown in EDS spectrum of Figure 5a. The map
corresponding to the distribution of the detected elements is represented in Figure 5b. Zn and O w re
the most abundant o es and uniformly distributed on the whol sample area. Th r fore, these w re
not included in the map. The presence of S (red) and N (blue) was then considered a qualitative
indication of GS adsorption, while P (pink) and Ca (yellow) were detected due to Calcium Phosphates
compounds’ precipitation deriving from the interaction of ZnO with SBF solution, as evidenced by the
IR spectra in Figure 4a.
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After loading in SBF for 2 h, the GS kinetic release profile was monitored against time, for up
to seven days in SBF at 37 ◦C. Figure 6 shows an important burst delivery, with around 90% GS
released within the first 2 h, then approaching 100% after 24 h and being stable around this value
for up to seven days. The release profile followed a zero-order exponential decay law (see the red
fitting curve), with a release rate constant of 3.69 ± 2.25 s−1, representing that GS release out from the
mesoporous matrix was driven by simple diffusion mechanism. An IR spectrum was also acquired on
the GS-loaded mesoporous ZnO at the end of the release experiment, i.e., after seven days, as shown
in Figure 7. The absence of the sulfate band at 609 cm−1 confirmed the complete GS release. At the
same time, the rise of PO43− vibrational modes in the range 600–550 cm−1 were due to CaP formation
after the prolonged exposure of the sample to SBF, as previously observed from EDS analyses.
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3. Discussion
Within the wide plethora of nanomaterials investigated for drug-delivery applications, the interest
in considering ZnO structures was somehow limited. This was mainly due to the lack of an intrinsic
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mesoporous structure, which could prevent drug molecule adsorption and release. Low-dimensional
ZnO structures, i.e., quantum dots and spherical nanoparticles, were successfully loaded alone
or in combination with MSNs, with anticancer drugs like doxorubicin [49,50,52,53]. The general
mechanism allowing for the controlled release of drug was driven by the sensitivity of ZnO to pH
variations [59]. In the present study, an alternative way to prepare mesoporous ZnO structures showing
drug adsorption and release properties was successfully demonstrated as well. The mesoporous ZnO
matrix was prepared by a two-step synthetic approach, involving the sputtering deposition of porous
metallic zinc layers and their following thermal oxidation. Gentamicin sulfate was effectively loaded
within the ZnO matrix, thanks to the high-surface area of the mesoporous framework combined with
the presence of hydroxyl groups. Both of these aspects allowed the drug molecule to be efficiently
loaded. An important drawback for ZnO nanomaterials is the low chemical stability when surrounded
by biological fluids [12]. This aspect was confirmed also in the present case. Depending on the GS
loading solution, the mesoporous ZnO matrix showed different behaviors and hence drug loading
efficiencies. When GS/H2O acidic solution was considered, drug loading was strongly limited by
degradation phenomena affecting the mesoporous ZnO matrix. This was represented by the Zn2+
release profile, showing that strong degradation of the porous structure occurred during uptake
experiments in GS/H2O. Therefore, drug loading was also performed considering a buffered GS/SBF
solution. In this case, no remarkable changes in Zn2+ concentration were observed after 24 h. Hence,
using a buffered GS/SBF solution allowed for strongly limiting the undesirable degradation of the
mesoporous ZnO matrix, maximizing GS loading at the same time.
All of the results showed that high surface area, crystalline and mesoporous ZnO structures could
effectively serve as a mesoporous matrix for GS adsorption. By considering degradation phenomena
generally affecting ZnO, suitable uptake conditions were selected, allowing the loading of 263 mg
GS per gram of active material. Finally, the GS-loaded mesoporous ZnO structures showed a fast
kinetic delivery, with around 100% drug being released within a few hours by a simple and obvious
diffusion mechanism.
By considering these promising findings, new future applications of mesoporous ZnO
structures as short-term type therapeutic devices could be envisioned. For example, their use as
antibiotic-releasing coatings might be exploited to design drug-eluting cardiovascular or ureteral
stents, bone and periodontal implants. Indeed, bacterial infections affecting the insertion of implants
still represent one of the main problems and should be treated in an efficient and short time manner.
In the case of more time-controlled release, we envision the possibility of further engineering
the chemical and physical structure of the ZnO mesopores or their entrance with smart coatings,
biodegradable polymer layers or stimuli-triggered compounds. These strategies will prevent
an uncontrolled and burst release of the drug from the whole mesoporous system, delaying the
drug rate to several hours and even days. In contrast, the delivery of the therapeutic agent can be
activated in a precise and time-controlled manner upon a specific stimulus. Ongoing studies are being
carried out to investigate the antibacterial efficacy of the proposed mesoporous ZnO structures in vitro.
Moreover, the citocompatibility of this novel mesoporous ZnO nanostructure towards living healthy
cells from epithelial and bone tissues is still under investigation.
4. Materials and Methods
Synthesis of mesoporous zinc oxide (ZnO) structures. Mesoporous ZnO samples (3 mg each) were
prepared by following a two-step synthetic approach, as previously described [7]. In the first step,
a metallic Zn layer was deposited at room temperature on silicon (Si) substrates (~1 cm2 area) by
radio-frequency magnetron sputtering for an overall deposition time of 4 h. Then, thermal oxidation of
the Zn-coated Si samples was performed in a muffle furnace at 380 ◦C (ramp rate 150 ◦C/h) in air for
2 h. Before Zn deposition, the Si substrates were cleaned in an ultrasonic bath of acetone and ethanol
(10 min for each washing cycle) and dried under nitrogen flow.
Materials 2018, 11, 314 8 of 11
Gentamicin sulfate (GS) adsorption and release experiments. GS powders were dissolved either
in bidistilled water or simulated body fluid (SBF) at room temperature, under continuous stirring
conditions (360 rpm) for 30 min. SBF salt solution was prepared according to Kokubo’s protocol [58].
Both GS/H2O and GS/SBF uptake solutions had a final concentration of 250 µg/mL. Adsorption of
GS was performed at room temperature by soaking the mesoporous ZnO/Si samples for different
times (1 h, 2 h, 5 h and 24 h) in a plastic tube filled with the uptake solution (5 mL), under orbital
shaking conditions (160 rpm). After GS uptake, all the samples were washed with bidistilled water
and air-dried overnight.
GS release experiments were carried out by soaking the GS-ZnO/Si samples in a plastic tube
filled with SBF (10 mL), in orbital conditions (160 rpm) at 37 ◦C for up to seven days. At specific points
of time (5 min, 15 min, 30 min, 1 h, 2 h, 4 h, 6 h, 24 h, 48 h, 72 h, 7 days), 350 µL aliquot was collected
from the release solution, centrifuged at 20,000× g for 5 min and analyzed by UV-Vis spectroscopy.
The drug release profile was then obtained by considering the characteristic GS absorbance peak at
251 nm. This was compared with a calibration curve obtained from the UV absorbance values at
251 nm of a series of GS dilutions in SBF (from 5 to 1000 µg/mL). The amount of drug at each release
time wt was obtained according to the following equation:
wt = Ct × Vt−1
where Ct is the concentration of the solution collected at each release time ti (being i an integer = 1,
2, . . . , n), while Vt is the residual volume of the release solution at that time, i.e., the starting release
volume (10 mL) depleted at each time point ti of a fixed volume (∆Vi = 350 µL). The cumulative GS
release profile was then obtained according to this equation:
wt (%) = (wt × w0−1) × 100
where w0 is the starting amount of GS loaded on the mesoporous matrix.
Sample characterization. The morphology of the samples was evaluated by means of Field-Emission
Scanning Electron Microscope (FESEM, Supra®40, Carl Zeiss AG, Oberkochen, Germany).
X-ray Diffraction measurements were performed by a Panalytical X’Pert PRO diffractometer in
Bragg-Brentano configuration, equipped with a Cu Kα monochromatic radiation (λ = 1.54059 Å)
as X-ray source. The chemical composition was investigated by Energy Dispersive Spectroscopy
(EDS), using a desktop SEM Phenom XL (Phenom-World B.V. part of Thermo Fisher Scientific,
Eindhoven, The Netherlands) equipped with an EDS analyzer. UV-Vis absorbance spectra were
collected in the range 200–285 nm, by means of a double-beam Varian Cary 5000 UV-vis-NIR
spectrophotometer (Milan, Italy). UV analysis of drug solutions were carried out in a quartz cuvette,
with an optical path length of 1 mm, analyzing a volume of 350 µL. All of the UV spectra were
background subtracted. IR spectroscopy was carried out with a Nicolet 5700 FTIR Spectrometer
(ThermoFisher, Waltham, MA, USA), equipped with a room temperature working L-alanine doped
triglycine sulfate (DLaTGS) detector. All of the spectra were background subtracted and acquired with
2 cm−1 resolution and 64 scans accumulation. The release profile for Zn2+ element was determined
with an Inductively Coupled Plasma Mass Spectrometer analyzer (ICP-MS, mod. 7500cc, Agilent
Technologies, Milan, Italy).
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